CMPB Central Pathology Support
CMPB Central Pathology Support
批准号:
7734576
负责人:
Robert Sills
金额:
$573.93万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ArtsAtherosclerosisBiological AssayBiological MarkersBloodBody FluidsCardiovascular DiseasesCellsClinicalClinical PathologyCollaborationsCommunitiesConsultationsDiseaseGene ExpressionGenesGoalsGrowth FactorHormonesImage AnalysisImmuneIndustryInflammatoryInsulinKidney DiseasesLaboratoriesLasersLeptinLung diseasesMediatingMedical ResearchMethodsMicrodissectionMolecular MachinesNon-Insulin-Dependent Diabetes MellitusObesityPathologyPerformancePopulationProcessRegulationResearch PersonnelScanningSerumSkeletal DevelopmentTechnical ExpertiseTestingTestosteroneTissuesTroponin TVascular Endothelial Growth FactorsWorkbasecytokinedietary restrictiondigital imagingfatty acid binding proteinfatty acid-binding proteinsinstrumentnew technologysample collection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Collaborative and support oriented work has over the past year had an impact in the study, and on the understanding, of a spectrum of diseases and disease processes such as cardiovascular disease (atherosclerosis), inflammatory respiratory disease, obesity and type II diabetes, inflammatory and immune-mediated renal disease, gene expression and gene regulation, axial skeletal development and transgenerational effects of diet restriction. To keep the clinical laboratory up-to-date, new methods and instruments have been obtained. For example, An Aperio Scan Scope has been added for digital imaging and imaging analysis of tissue sections. A CellCut laser microdissection scope (Molecular Machines and Industries) has been incorporated for the targeting and capture of specific cells or cell populations. Additionally, a SECTOR Imager 2400 by Meso Scale Discovery was obtained for the performance of a variety of serum biomarkers, in single- or multi-plex fashion, including, but not limited to, troponin T and I, fatty acid binding protein 3, inflammatory cytokines (e.g., interlukins, TNFa, INFg), growth factors (e.g., VEGF), hormones (e.g., insulin, leptin, etradiol, progeterone, testosterone).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
-
批准号:7967965
-
项目类别:
-
资助金额:$26.4万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
-
批准号:8734053
-
项目类别:
-
资助金额:$69.1万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Genetic Alterations In Rodent Cancer
-
批准号:8734052
-
项目类别:
-
资助金额:$122.99万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
CMPB Central Pathology Support
-
批准号:8554221
-
项目类别:
-
资助金额:$1069.43万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
CMPB Central Pathology Support
-
批准号:8177762
-
项目类别:
-
资助金额:$724.55万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
-
批准号:8148986
-
项目类别:
-
资助金额:$26.62万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Genetic Alterations In Rodent Cancer
-
批准号:8148985
-
项目类别:
-
资助金额:$124.21万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
CMPB Central Pathology Support
-
批准号:9143533
-
项目类别:
-
资助金额:$1297.31万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Genetic Alterations In Rodent Cancer
-
批准号:8336525
-
项目类别:
-
资助金额:$81.31万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
-
批准号:8553680
-
项目类别:
-
资助金额:$106.44万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Genetic Alterations In Rodent Cancer
-
批准号:8553679
-
项目类别:
-
资助金额:$118.41万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
CMPB Central Pathology Support
-
批准号:8734196
-
项目类别:
-
资助金额:$1004.16万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Genetic Alterations In Rodent Cancer
-
批准号:7967962
-
项目类别:
-
资助金额:$152.52万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
CMPB Central Pathology Support
-
批准号:8336734
-
项目类别:
-
资助金额:$743.03万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
-
批准号:8336526
-
项目类别:
-
资助金额:$73.09万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
CMPB Central Pathology Support
-
批准号:8929839
-
项目类别:
-
资助金额:$1228.05万
-
财政年份:--
-
负责人:Robert Sills
-
依托单位:
海外基金